Foldax Tria™ LifePolymer™ heart valve technology wins “Medical Device Engineering Breakthrough Award” in the fourth annual MedTech Breakthrough Awards...
Read more
Foldax, Inc. announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for...
Read more
Kairos Ventures portfolio company Foldax Inc. announced the U.S. Food and Drug Administration (FDA) has granted investigative device exemption...
Read more
We are excited to announce that Foldax is the latest company to join our portfolio, following our investment in...
Read more